| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/06/2003 | EP1332513A2 Detecting polymers and polymer fragments |
| 08/06/2003 | EP1332371A2 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 08/06/2003 | EP1332222A2 Metabolic rate shifts in fermentations expressing recombinant proteins |
| 08/06/2003 | EP1332216A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 08/06/2003 | EP1332209A2 Collections of repeat proteins comprising repeat modules |
| 08/06/2003 | EP1332159A1 Process for the preparation of latent antithrombin iii |
| 08/06/2003 | EP1332157A2 Prokineticin polypeptides, related compositions and methods |
| 08/06/2003 | EP1332156A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 08/06/2003 | EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 08/06/2003 | EP1332153A1 Human ect2 and methods of use |
| 08/06/2003 | EP1105051A4 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 08/06/2003 | EP1015570A4 Fibrin microbeads and uses thereof |
| 08/06/2003 | EP0791076A4 Diagnostic method and kit for determining kell blood group genotype |
| 08/06/2003 | CN1434865A Regulation effect of conjugated frame transport protein ABC1 |
| 08/06/2003 | CN1434832A DNA for encoding the RGI polypeptide |
| 08/06/2003 | CN1434125A Method for producing single cell protein using residue in extracting steroid sepogenin |
| 08/06/2003 | CN1434124A Method for producing collagen oligopeptide |
| 08/06/2003 | CN1434121A Fermentation production technology for olry bacterial powder containing gama-linolenic acid |
| 08/06/2003 | CN1434057A Process for preparing reversible photochromic biliprotein |
| 08/06/2003 | CN1117160C Process for the preparation of recombinant proteins in E coli by high cell density fermentation |
| 08/06/2003 | CN1117155C Novel compounds |
| 08/06/2003 | CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic |
| 08/05/2003 | US6602986 Antibody comprising a heavy and light chain, each comprising three nonnaturally occuring chain determining regions; antibody specifically binds to human antigen |
| 08/05/2003 | US6602978 Polypeptide, of given amino acid sequence, specific for binding to a receptor; antibodies against the peptides are useful for enhancing or inhibiting inflammation and early effects of wound healing |
| 08/05/2003 | US6602854 Branched multimeric Apo A-I agonist compounds |
| 08/05/2003 | US6602707 Mammalian cell surface DNA receptor-encoding nucleic acid |
| 08/05/2003 | US6602705 Expression of HIV polypeptides and production of virus-like particles |
| 08/05/2003 | US6602699 Recombinant DNA fragment comprising the Saccharomyces cerevisiae YNL 279 w gene promoter which, when functionally linked to a structural gene, regulates transcription thereof |
| 08/05/2003 | US6602697 Process for purifying human papillomavirus virus-like particles |
| 08/05/2003 | US6602689 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein |
| 08/05/2003 | US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage |
| 08/05/2003 | US6602685 Compounds immobilized on a solid support; parallel screening; efficiency |
| 08/05/2003 | US6602684 Culturing a host cell to express a nucleic acid encoding beta (1,4)-N- acetylglucosaminyltransferase III under conditions for production of a polypeptide; can use to provide proteins with improved therapeutic properties |
| 08/05/2003 | US6602683 Biologically active Eph family ligands |
| 08/05/2003 | US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions |
| 08/05/2003 | US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/05/2003 | CA2202549C Transgenic nonhuman animal having functionally disrupted interleukin-1.beta. converting enzyme gene |
| 07/31/2003 | WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | WO2003062428A1 Genetic sequences having methyltransferase activity and uses therefor |
| 07/31/2003 | WO2003062424A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/31/2003 | WO2003062382A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 07/31/2003 | WO2003062370A2 Multimeric proteins and methods of making and using same |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003062276A2 Multimers of receptor-binding ligands |
| 07/31/2003 | WO2003062274A1 Novel proteins and dnas thereof |
| 07/31/2003 | WO2003062270A2 Fluorescent protein from aequorea coerulscens and uses therof |
| 07/31/2003 | WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | WO2003061562A2 Production of recombinant therapeutic bioscavengers against chemical and biological agents |
| 07/31/2003 | WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | WO2003061363A2 Mutations caused by activation-induced cytidine deaminase |
| 07/31/2003 | WO2003046160A3 Methods of increasing protein expression levels |
| 07/31/2003 | WO2003031571A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/31/2003 | WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/31/2003 | WO2003006607A3 Inhibition of apoptosis process and improvement of cell performance |
| 07/31/2003 | WO2003006499A3 Survivin interacting protein tpr1 |
| 07/31/2003 | WO2003002736A3 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 07/31/2003 | WO2003001870A3 Methods for making antibody fragments and compositions resulting therefrom |
| 07/31/2003 | WO2003000024A3 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 07/31/2003 | WO2002101005A3 A g-protein coupled receptor and uses therefor |
| 07/31/2003 | WO2002086123A3 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof |
| 07/31/2003 | WO2002059148A3 A method for identification, isolation and production of antigens to a specific pathogen |
| 07/31/2003 | WO2002047730A3 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 07/31/2003 | WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 07/31/2003 | WO2002027005A3 Enhanced transfection system |
| 07/31/2003 | WO2002024909A3 Receptor nucleic acids and polypeptides |
| 07/31/2003 | WO2002020847A3 Gene and sequence variation associated with lipid disorder |
| 07/31/2003 | WO2002018444A3 Erbb4 antagonists |
| 07/31/2003 | WO2002012286A3 Stress proteins and peptides and methods of use thereof |
| 07/31/2003 | WO2002004489A3 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 07/31/2003 | WO2001096870A3 Immunoassays for anti-hcv antibodies |
| 07/31/2003 | WO2001085912A3 Presenilin enhancers |
| 07/31/2003 | US20030145347 Grain processing method and transgenic plants useful therein |
| 07/31/2003 | US20030145342 Activation; transgenic rodent; genetic engineering |
| 07/31/2003 | US20030144492 Anticancer agents; central nervous system disorders; antiinflammatory agents |
| 07/31/2003 | US20030144482 Diagnosis of skin cancer; vaccine |
| 07/31/2003 | US20030144480 Genetic engineering; medical diagnosis |
| 07/31/2003 | US20030144476 Genetic engineered polypeptide; medical diagnosis |
| 07/31/2003 | US20030144475 Human protein and cdna |
| 07/31/2003 | US20030144473 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 07/31/2003 | US20030144211 Inhibit leukocyte adhesion to endothelium or to platelets |
| 07/31/2003 | US20030144209 Bone anabolic agents for the treatment of bone disease |
| 07/31/2003 | US20030144200 Novel forms of the angiogenic factor vascular endothelial cell growth factor: VEGF |
| 07/31/2003 | US20030144197 Autologous growth factor cocktail composition, method of production and use |
| 07/31/2003 | US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica) |
| 07/31/2003 | US20030144187 Comprising an osteoprotegerin polypeptide and an immunoglobulin FC region; treatment of bone disorders |
| 07/31/2003 | US20030143735 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 07/31/2003 | US20030143734 Amino acid transporters and uses |
| 07/31/2003 | US20030143716 Selection media for beauveriolide I or beauveriolide III and process for selectively producing these substances |
| 07/31/2003 | US20030143707 Proteins having DNA repair promoting activity |
| 07/31/2003 | US20030143697 Nucleic acid encoding a fusion polypeptide that forms a multimer that binds to a cytokine to form a nonfunctional complex; cytokine antagonists for the treatment of cytokine-related diseases or disorders |
| 07/31/2003 | US20030143691 Human testin |
| 07/31/2003 | US20030143690 Peptides and proteins that effect protein phosphorylation; genetic engineered DNA; useful for therapy and diagnosis |
| 07/31/2003 | US20030143685 Nucleic acid expression control sequence cassettes comprising a stable bacteriophage T5 promoter and nucleic acid regulatory sequences, useful for generating stable expressin vectors of high-level protein expression; culture product |
| 07/31/2003 | US20030143684 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 07/31/2003 | US20030143683 Introducing a nucleotide sequence encoding prefered amino acid sequences in into a host cell and culturing the host cell in which the peptides are expressed from the nucleotide sequence; human therapeutics and diagnostic protein |
| 07/31/2003 | US20030143679 Genes encoding insect odorant receptors and uses thereof |
| 07/31/2003 | US20030143674 Polypeptides fused to heterologous polypeptide sequences, and an antibodies which bind to the above polypeptides |
| 07/31/2003 | US20030143669 Contacting a mammalian cell culture expressing a lysosomal hydrolase with a mutagenic agent; culturing culture in presence of pseudomonas exotoxin A to select for cell resistant to the pseudomonas, isolating lysosomal hydrolase |
| 07/31/2003 | US20030143667 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/31/2003 | US20030143664 Products of manufacture and processes for peptide synthesis |